174 related articles for article (PubMed ID: 34754077)
81. PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
Chen H; Wei L; Luo M; Wang X; Zhan Y; Mao Y; Huang C; Li J; Lu H
Environ Toxicol; 2021 Nov; 36(11):2291-2301. PubMed ID: 34363436
[TBL] [Abstract][Full Text] [Related]
82. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
83. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
84. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
85. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
[TBL] [Abstract][Full Text] [Related]
86. Inhibition of the P53/P21 Pathway Attenuates the Effects of Senescent Nucleus Pulposus Cell-Derived Exosomes on the Senescence of Nucleus Pulposus Cells.
Chen CC; Chen J; Wang WL; Xie L; Shao CQ; Zhang YX
Orthop Surg; 2021 Apr; 13(2):583-591. PubMed ID: 33314719
[TBL] [Abstract][Full Text] [Related]
87. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
He AR; Zhu Q; Gao S
Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
[TBL] [Abstract][Full Text] [Related]
88. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
89. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
[TBL] [Abstract][Full Text] [Related]
90. Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.
Li Q; Ni W; Deng Z; Liu M; She L; Xie Q
Fundam Clin Pharmacol; 2017 Jun; 31(3):301-310. PubMed ID: 28078787
[TBL] [Abstract][Full Text] [Related]
91. Adiponectin suppresses tumor growth of nasopharyngeal carcinoma through activating AMPK signaling pathway.
Zhang Z; Du J; Shi H; Wang S; Yan Y; Xu Q; Zhou S; Zhao Z; Mu Y; Qian C; Zhao AZ; Cao S; Li F
J Transl Med; 2022 Feb; 20(1):89. PubMed ID: 35164782
[TBL] [Abstract][Full Text] [Related]
92. A preclinical evaluation of thiostrepton, a natural antibiotic, in nasopharyngeal carcinoma.
Hsu YB; Lan MC; Kuo YL; Huang CF; Lan MY
Invest New Drugs; 2020 Apr; 38(2):264-273. PubMed ID: 30993588
[TBL] [Abstract][Full Text] [Related]
93. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
[TBL] [Abstract][Full Text] [Related]
94. Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma.
Chiang C; Zhang M; Wang D; Xiao T; Zhu L; Chen K; Huang J; Huang J; Zhu J; Li L; Chen C; Chen Y; Hu H; Jiang W; Zou Y; Wang T; Zheng D
Theranostics; 2020; 10(17):7906-7920. PubMed ID: 32685028
[No Abstract] [Full Text] [Related]
95. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
[TBL] [Abstract][Full Text] [Related]
96. EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells.
Ma X; Xu Z; Yang L; Xiao L; Tang M; Lu J; Xu S; Tang Y; Wen X; Deng X; Sun L; Cao Y
Int J Oncol; 2013 Nov; 43(5):1541-8. PubMed ID: 24042231
[TBL] [Abstract][Full Text] [Related]
97. EGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.
Fang CY; Wu CC; Hsu HY; Chuang HY; Huang SY; Tsai CH; Chang Y; Tsao GS; Chen CL; Chen JY
Int J Mol Sci; 2015 Jan; 16(2):2530-58. PubMed ID: 25625511
[TBL] [Abstract][Full Text] [Related]
98. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex.
Madan E; Gogna R; Kuppusamy P; Bhatt M; Pati U; Mahdi AA
Br J Cancer; 2012 Jul; 107(3):516-26. PubMed ID: 22782351
[TBL] [Abstract][Full Text] [Related]
99. DNA damage checkpoints in nasopharyngeal carcinoma.
Poon RY
Oral Oncol; 2014 May; 50(5):339-44. PubMed ID: 24503238
[TBL] [Abstract][Full Text] [Related]
100. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
